INVO Bioscience (INVO Bioscience) Price-to-Operating-Cash-Flow : (As of Jun. 12, 2024)

View and export this data going back to 2020. Start your Free Trial

What is INVO Bioscience Price-to-Operating-Cash-Flow?

As of today (2024-06-12), INVO Bioscience's share price is $0.7349. INVO Bioscience's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.30. Hence, INVO Bioscience's Price-to-Operating-Cash-Flow Ratio for today is .

The historical rank and industry rank for INVO Bioscience's Price-to-Operating-Cash-Flow or its related term are showing as below:

During the past 13 years, INVO Bioscience's highest Price-to-Operating-Cash-Flow Ratio was 30.36. The lowest was 17.97. And the median was 23.89.

INVO's Price-to-Operating-Cash-Flow is not ranked ^*
in the Medical Devices & Instruments industry.
Industry Median: 20.69
* Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.

INVO Bioscience's Cash Flow from Operations per share for the three months ended in Mar. 2024 was $-0.07. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 was $-3.30.

During the past 3 years, the average Operating Cash Flow per Share Growth Rate was 44.10% per year.

During the past 13 years, INVO Bioscience's highest 3-Year average Operating Cash Flow per Share Growth Rate was 68.70% per year. The lowest was -759.10% per year. And the median was -47.20% per year.

INVO Bioscience Price-to-Operating-Cash-Flow Historical Data

The historical data trend for INVO Bioscience's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

INVO Bioscience Price-to-Operating-Cash-Flow Chart

INVO Bioscience Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Operating-Cash-Flow

Get a 7-Day Free Trial

24.63

INVO Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Price-to-Operating-Cash-Flow	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of INVO Bioscience's Price-to-Operating-Cash-Flow

For the Medical Devices subindustry, INVO Bioscience's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

INVO Bioscience's Price-to-Operating-Cash-Flow Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, INVO Bioscience's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where INVO Bioscience's Price-to-Operating-Cash-Flow falls into.

INVO Bioscience Price-to-Operating-Cash-Flow Calculation

INVO Bioscience's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio	=	Share Price	/	Cash Flow from Operations per share (TTM)
	=	0.7349	/	-3.304
	=

INVO Bioscience's Share Price of today is $0.7349.
INVO Bioscience's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $-3.30.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio

Market Cap

Cash Flow from Operations

INVO Bioscience Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of INVO Bioscience's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

INVO Bioscience (INVO Bioscience) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » INVO Bioscience Inc (NAS:INVO) » Definitions » Price-to-Operating-Cash-Flow

Comparable Companies

Traded in Other Exchanges

N/A

Address

5582 Broadcast Court, Sarasota, FL, USA, 34240

Website

https://www.invobio.com

INVO Bioscience Inc operates as a medical device company focused on the Assisted Reproductive Technology (ART) marketplace that is creating simplified, lower-cost treatments for patients diagnosed with infertility. The company has developed the INVOcell device and procedure, the first Intravaginal Culture (IVC) system granted FDA clearance in the United States used for the incubation of eggs and sperm during fertilization and early embryo development. The company sells its products to physicians directly; and IVF centers, medical practices, and physicians through distributors.

Executives

Trent D Davis	director	811 SW NAITO PARKWAY, SUITE 200, PORTLAND OR 97204
Matthew K Szot	director	802 NORTH DOUTY STREET, HANFORD CA 93230
Steve Shum	director	9025 SW HILLMAN COURT, SUITE 3126, WILSONVILLE OR 97070
Andrea Goren	officer: Chief Financial Officer	110 EAST 59TH STREET, SUITE 1901, NEW YORK NY 10022
Barbara Ryan	director	22 CAVRAY ROAD, NORWALK CT 06855
Michael Jos. Campbell	director	61 SOUTH HILLS DRIVE, BEDFORD NH 03110
Rebecca Messina	director	5582 BROADCAST COURT, SARASOTA FL 34240
Jeffrey Segal	director	INVO BIOSCIENCE, INC., 5582 BROADCAST COURT, SARASOTA FL 34240
Awm Investment Company, Inc.	10 percent owner	527 MADISON AVENUE, SUITE 2600, NEW YORK NY 10022
Kevin Doody	director, officer: Medical Director	1109 SOMERSET BLVD, COLLEYVILLE TX 76034
Debra Robbins Hoopes	officer: Acting CFO and PFO	1 MORTON DR., SUITE 200, CHARLOTTESVILLE VA 22903
Claude Ranoux	10 percent owner	8 CHESTNUT STREET, WINCHESTER MA 01890
Kathleen T Karloff	director, officer: CEO/Chairman	109 BEACON STREET UNIT 5, BOSTON MA 02116
Bowdring Robert Joseph Jr	officer: Chief Financial Officer	92 GOULD STREET, WAKEFIELD MA 01880